Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged 18 or older who have recently given birth
- People who have been diagnosed with a blood pressure condition during pregnancy, such as gestational hypertension, chronic hypertension, or preeclampsia (with or without severe features)
- People currently taking Nifedipine 60 mg every 12 hours to manage blood pressure
- People whose blood pressure has remained at or above 140/90 mmHg over a 24-hour period, or who have had at least one reading at or above 160/110 mmHg requiring an additional blood pressure medication
- People who speak English
Who may not be able to join:
- People who were taking two or more blood pressure medications during pregnancy
- People who have a condition called heart block (a problem with the heart's electrical signals)
- People whose resting heart rate is below 60 or above 120 beats per minute
- People who have heart failure
- People with a blood test result showing creatinine levels above 1.5 mg/dL, which can indicate reduced kidney function (confirm with trial site)
- People who have a narrowing of the arteries that supply the kidneys, known as renal artery stenosis
- People with an active connective tissue disease, such as lupus or similar conditions
- People who have had a stroke
- People for whom treatment with nifedipine, enalapril, or labetalol has not worked or is medically unsuitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Amol Malshe, M.D., The Cleveland Clinic
Phone: 216 903-9646
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Composite postpartum hypertension treatment failure within 6 weeks postpartum
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.